NBIX
Neurocrine Biosciences Inc
stockNASDAQ
neurocrine biosciences, inc of san diego is a product based biopharmaceutical company focusing on the development and commercialization of innovative pharmaceutical products to treat unmet medical needs. the company's research and development efforts are focused on neurological and endocrine diseases and disorders. our product candidates address some of the largest pharmaceutical markets in the world including endometriosis, irritable bowel syndrome, anxiety, depression, pain, diabetes, insomnia, and other neurological and endocrine related diseases and disorders
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 136.98 | 2026-10-19 | +4.18% | 0.219 |
| 1M | 138.40 | 2026-09-25 | +3.11% | 0.440 |
| 3M | 175.77 | 2026-07-24 | -18.81% | 0.181 |
| 6M | 127.68 | 2026-04-24 | +11.77% | 0.345 |
| 1Y | 144.00 | 2025-10-24 | -0.90% | 0.616 |
| 2Y | 116.08 | 2024-10-25 | +22.94% | — |
| 5Y | 102.55 | 2021-10-25 | +39.16% | 0.587 |
Neurocrine Biosciences Inc (NASDAQ:NBIX) stock price today is $142.71, and today's volume is 1,033,372. NBIX is down 0.405% today. The 30 day average volume is 1.37M. NBIX market cap is $14.51B with 101.65M shares outstanding.